国际外科学杂志
國際外科學雜誌
국제외과학잡지
INTERNATIONAL JOURNAL OF SURGERY
2011年
4期
221-225,封3
,共6页
邱继刚%翁永强%唐健雄%袁祖荣
邱繼剛%翁永彊%唐健雄%袁祖榮
구계강%옹영강%당건웅%원조영
癌,肝细胞%转胶蛋白%组织芯片%生物标志物
癌,肝細胞%轉膠蛋白%組織芯片%生物標誌物
암,간세포%전효단백%조직심편%생물표지물
Carcinoma,hepatocellular%Transgelin%Tissue microarray%Biomarker
目的 研究肝癌中转胶蛋白(Transgelin)表达预测肝癌切除术患者复发及预后的临床意义.方法 应用组织芯片结合免疫组织化学染色检测43例肝癌切除术患者肝癌和癌周组织的Transgelin表达水平.以Logrank检验、Kaplan-Meier分析以及多因素Cox回归分析其表达水平与肝癌患者预后的关系.结果 Transgelin在肝癌组织中的表达明显高于癌旁组织,Transgelin在癌组织中的表达与肿瘤大小、门静脉癌栓、肿瘤TNM分期以及术前血清AFP水平呈正相关性.Transgelin阳性表达的患者术后无瘤生存率明显低于阴性表达者(P<0.01).多因素Cox回归分析显示,Transgelin是影响术后无瘤生存率的独立预后因素之一(P<0.01).结论 Transgelin与肝癌患者术后复发密切相关,可作为判断肝癌切除术预后的生物标志物.
目的 研究肝癌中轉膠蛋白(Transgelin)錶達預測肝癌切除術患者複髮及預後的臨床意義.方法 應用組織芯片結閤免疫組織化學染色檢測43例肝癌切除術患者肝癌和癌週組織的Transgelin錶達水平.以Logrank檢驗、Kaplan-Meier分析以及多因素Cox迴歸分析其錶達水平與肝癌患者預後的關繫.結果 Transgelin在肝癌組織中的錶達明顯高于癌徬組織,Transgelin在癌組織中的錶達與腫瘤大小、門靜脈癌栓、腫瘤TNM分期以及術前血清AFP水平呈正相關性.Transgelin暘性錶達的患者術後無瘤生存率明顯低于陰性錶達者(P<0.01).多因素Cox迴歸分析顯示,Transgelin是影響術後無瘤生存率的獨立預後因素之一(P<0.01).結論 Transgelin與肝癌患者術後複髮密切相關,可作為判斷肝癌切除術預後的生物標誌物.
목적 연구간암중전효단백(Transgelin)표체예측간암절제술환자복발급예후적림상의의.방법 응용조직심편결합면역조직화학염색검측43례간암절제술환자간암화암주조직적Transgelin표체수평.이Logrank검험、Kaplan-Meier분석이급다인소Cox회귀분석기표체수평여간암환자예후적관계.결과 Transgelin재간암조직중적표체명현고우암방조직,Transgelin재암조직중적표체여종류대소、문정맥암전、종류TNM분기이급술전혈청AFP수평정정상관성.Transgelin양성표체적환자술후무류생존솔명현저우음성표체자(P<0.01).다인소Cox회귀분석현시,Transgelin시영향술후무류생존솔적독립예후인소지일(P<0.01).결론 Transgelin여간암환자술후복발밀절상관,가작위판단간암절제술예후적생물표지물.
Objective To study the clinical meaning of Transgelin expression in heptacellular carcinoma(HCC) in prognosing recurrence after hepatectomy. Methods The expression of Transgelin in cancerous lesions and tissue adjacent to cancer lesions from 223 operation samples was detected by immunohistochemical staining combined with tissue microarray techniques. The correlation between the level of Transgelin expression and the prognosis was analyzed by means of log- rank test, Kaplan- Meier analysis and multivariate Cox regression analysis. Results Transgelin was higher expressed in tumor tissue than in tissue adjacent to cancer lesions. Transgelin was positively correlated with the presence of tumor size, portal vein invasion, pTNM tumor stages and serum AFP level. Patients with positive expression of Transgelin had worse tumor free survival than those with negative ones (P <0. 01). The multivariate Cox regression analysis showed that Transgelin expression level was one of the independent prognostic factors in tumor free survival after surgery. Conclusions The expression of Transgelin in hepatocellular carcinoma was significantly associated with recurrence in patients with HCC after hepatectomy, and this protein could be the biomarker of the prognosis in HCC surgery.